Last updated: April 24, 2026
What products are in scope?
The query points to heparin sodium supplied as:
- Strength: 1,000 Units
- Diluent: Sodium chloride 0.9%
- Container: plastic
Commercial labeling for this category commonly appears as heparin sodium in 0.9% sodium chloride, preservative-free single/multi-dose vial or bag, used for IV administration or line flush/maintenance. The exact container format (vial vs bag), pack size, and whether it is preservative-free changes manufacturer lists and supply.
Who are the suppliers/manufacturers (commercially marketed) for heparin sodium in 0.9% sodium chloride in plastic containers?
Below are the major suppliers that market heparin sodium in sodium chloride 0.9% (plastic container formats vary by market and pack configuration). This list covers companies that are established manufacturers and/or marketers of injectable heparin sodium products across regions.
Global injectable heparin sodium supply participants
| Supplier / Manufacturer |
Product positioning in scope |
Market presence signal |
| Baxter International |
Injectable heparin sodium products in saline, commonly supplied for hospital use in plastic packaging formats in certain markets |
Large hospital-IV portfolio; long-running injectable manufacturing footprint |
| B. Braun |
Injectable heparin sodium in saline formats in multiple geographies |
European hospital supply chain; diversified sterile injectables |
| Hospira (Pfizer) |
Heparin sodium injectable lines used in hospital settings (market-specific presentations) |
Major historical branded generic injectable supplier |
| Sagent / EUSA / Axia (market-dependent brand structures) |
Heparin sodium sterile injectables in saline presentations |
Strong presence in generic injectable procurement networks |
| Teva |
Heparin sodium injectable portfolio (presentation varies by market) |
Broad sterile injectables manufacturing base |
| Sandoz (Novartis) |
Heparin sodium sterile injectables (saline presentations vary) |
Large generic injectable manufacturer |
| Hospira legacy and successor entities |
Heparin sodium injectable supply that shifts by regulatory region |
Portfolio transitions common across sterile injectables |
Which suppliers are most likely to match "plastic container" explicitly?
“Plastic container” is a packaging attribute used in distribution catalogs for sterile injectables delivered in plastic vials/bottles, prefilled syringes, or bags, depending on region. In practice, the suppliers above cover the dominant routes to plastic-container presentations because these companies run sterile injectable packaging lines (plastic primary containers) and sell through hospital tenders.
Supplier coverage by procurement channel
1) Hospital tender networks (dominant in EU/UK/ANZ)
Procurement tends to consolidate around suppliers with:
- broad sterile injectable portfolios
- stable supply in saline-diluted products
- ability to supply plastic presentations at scale
Typical participants: B. Braun, Baxter, Teva, Sandoz, and Pfizer/Hospira successor products (market dependent).
2) US distribution (presentation varies by NDC/labeling)
In the US, the same API strength may be supplied with different container formats by labeler and NDC. The “plastic container” qualifier often maps to:
- prefilled/packaged saline-diluted heparin presentations for hospital use
- packaging-specific NDC label differences that do not always appear in international catalogs
Key market players remain Baxter and legacy Hospira/Pfizer lines, with Teva/Sandoz as common generic suppliers depending on the exact NDC.
3) Middle East and emerging markets
Tender lists often mirror EU generic injectable patterns, with local importers adding heparin sodium from major sterile injector manufacturers such as B. Braun, Baxter, Sandoz, and Teva.
What procurement fields decide which supplier can be used?
Even with the same strength and diluent, suppliers differ by:
- container type (vial vs bag vs prefilled)
- preservative status (preservative-free vs with preservative)
- pack size (single unit vs multi-pack)
- sterility assurance and release site
- local regulatory listing (country-specific approval)
For tender qualification, these fields typically determine whether a supplier can be used under your product specification.
Key Takeaways
- The specification “heparin sodium 1,000 units in sodium chloride 0.9% in plastic container” maps to a hospital injectable presentation that is supplied by major sterile injectable manufacturers with plastic packaging capability.
- The practical supplier set for this category is dominated by large injectable suppliers and their branded or generic label structures: Baxter, B. Braun, Pfizer/Hospira lineage, Teva, and Sandoz.
- Actual “plastic container” compliance is label and NDC/country listing dependent; matching suppliers requires aligning container type and pack configuration to the exact labeled presentation used in procurement.
FAQs
1) Are Baxter and B. Braun the most reliable sources for plastic-container saline heparin presentations?
Yes, they are consistently present in hospital supply chains for saline-diluted injectable products, including plastic packaging formats that appear in tender catalogs.
2) Does Pfizer/Hospira still supply heparin sodium in this format?
Pfizer maintains the Hospira legacy supply footprint through labeler/manufacturer transitions that vary by country and NDC; the heparin sodium injectable portfolio is typically present, with packaging differing by market.
3) Do Teva and Sandoz supply the same strength and diluent across regions?
They supply heparin sodium sterile injectables, but the exact strength, diluent, and plastic container configuration can vary by local listing and label.
4) What specification items most often block a supplier from tender approval?
Container type (vial vs bag vs prefilled), preservative status, pack size, and the exact regulatory listing (NDC or country approval).
5) Is “plastic container” guaranteed if the product is heparin sodium in 0.9% saline?
No. Packaging is presentation-specific, so suppliers must match the exact labeled plastic-container format used in the procurement dossier.
References (APA)
[1] Baxter International Inc. Product portfolio and sterile injectable supply information.
[2] B. Braun. Sterile injectable product listings and hospital supply catalogs.
[3] Pfizer Inc. (Hospira legacy). Injectable portfolio documentation and market listings.
[4] Teva Pharmaceuticals. Sterile injectable product information and labeler/manufacturer listings.
[5] Sandoz (Novartis). Injectable product catalogs and sterile injectable listings.
